Email this article 
Hide
Show all
Original Research
Baseline CD4 and mortality trends in the South African human immunodeficiency virus programme: Analysis of routine data
Submitted: 05 March 2019 | Published: 24 July 2019
About the author(s)
Rivka R. Lilian, Anova Health Institute, Johannesburg, South AfricaKate Rees, Anova Health Institute, Johannesburg, South Africa; and, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
Moyahabo Mabitsi, Anova Health Institute, Johannesburg, South Africa
James A. McIntyre, Anova Health Institute, Johannesburg, South Africa; and, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
Helen E. Struthers, Anova Health Institute, Johannesburg, South Africa; and, Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa
Remco P.H. Peters, Anova Health Institute, Johannesburg, South Africa; and, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; and, Department of Medical Microbiology, School of Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre, Maastricht, the, Netherlands
Abstract
Background: Despite widespread availability of antiretroviral therapy (ART) in South Africa, there remains a considerable burden of human immunodeficiency virus (HIV)-related morbidity and mortality.
Objectives: To describe ART initiation and outcome trends over time, with a focus on clients presenting with advanced HIV-infection, so as to identify interventions to reduce morbidity and mortality.
Methods: Routine TIER.Net data from HIV-infected adults who had a documented baseline CD4 count and were newly initiating ART in Johannesburg or Mopani districts from 2004 to 2017 were analysed. Trends in baseline CD4 count and 5-year mortality were investigated and the population initiating ART with CD4 < 200 cells/mm3 was described.
Results: The Johannesburg and Mopani data sets comprised 203 131 and 101 814 records, respectively. Although median CD4 count increased over time, the proportion of initiations at CD4 < 200 cells/mm3 in 2017 remained high (Johannesburg 39%, Mopani 35%). Mortality was significantly increased among clients with CD4 < 200 compared to those with higher baseline counts (p < 0.001). Even though mortality among clients with low CD4 declined over time, likely because of improved drug regimens, in 2016–2017 mortality was still significantly increased among these clients (p < 0.001). Delivery of cotrimoxazole prophylaxis to clients with low CD4 declined over time to < 30% in 2017 and was associated with clinical stage. Presentation with CD4 < 200 cells/mm3 was associated with older age, male gender and hospitalisation.
Conclusion: A concerningly large proportion of South Africans still initiate ART at low CD4 counts. This is associated with increased mortality and requires targeted interventions to improve delivery of prophylactic regimens and early engagement in care.
Keywords
Metrics
Total abstract views: 4961Total article views: 6043
Crossref Citations
1. Prevalence of HIV, viral hepatitis B/C and tuberculosis and treatment outcomes among people who use drugs: Results from the implementation of the first drop-in-center in Mozambique
Cynthia Semá Baltazar, Timothy A. Kellogg, Makini Boothe, Anne Loarec, Ernesto de Abreu, Manuel Condula, Erika Fazito, Henry F. Raymond, Marleen Temmerman, Stanley Luchters
International Journal of Drug Policy vol: 90 first page: 103095 year: 2021
doi: 10.1016/j.drugpo.2020.103095
2. Altered cardiac structure and function in newly diagnosed people living with HIV: a prospective cardiovascular magnetic resonance study after the initiation of antiretroviral treatment
Pieter-Paul S. Robbertse, Anton F. Doubell, Jan Steyn, Carl J. Lombard, Mohammed A. Talle, Philip G. Herbst
The International Journal of Cardiovascular Imaging vol: 39 issue: 1 first page: 169 year: 2022
doi: 10.1007/s10554-022-02711-y
3. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017
Nadine Mayasi Ngongo, Gilles Darcis, Hippolyte Situakibanza Nanituna, Marcel Mbula Mambimbi, Nathalie Maes, Murielle Longokolo Mashi, Ben Bepouka Izizag, Michel Moutschen, François Lepira Bompeka, Kwasi Torpey
PLOS ONE vol: 16 issue: 11 first page: e0259073 year: 2021
doi: 10.1371/journal.pone.0259073
4. Evaluation of Treatment Outcomes Among Individuals on Highly Active Antiretroviral Therapy in KwaZulu‐Natal, South Africa
Tambwe Willy Muzumbukilwa, Riziki Ghislain Manimani, Aganze Gloire-Aime Mushebenge, Rajesh Vikram Vagiri, Manimbulu Nlooto, Kirtimaan Syal
AIDS Research and Treatment vol: 2024 issue: 1 year: 2024
doi: 10.1155/arat/8834740
5. The initiation of human immunodeficiency virus treatment for children at different levels of care
Wayne Sheldon Rajah, Kevin Bryant Spicer, Tyrone Nicholas Rajah, Jaques Johan van Heerden
African Journal of AIDS Research vol: 19 issue: 4 first page: 304 year: 2020
doi: 10.2989/16085906.2020.1836006
6. Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model
Gabriela E. Patten, Jonathan Euvrard, Nanina Anderegg, Andrew Boulle, Kirsten D. Arendse, Erin von der Heyden, Nathan Ford, Mary-Ann Davies
AIDS vol: 37 issue: 3 first page: 513 year: 2023
doi: 10.1097/QAD.0000000000003442
7. Drivers of disengagement from care during the first six months on antiretroviral therapy for HIV in South Africa: A mixed-methods study
Mhairi Maskew, Nyasha Mutanda, Nancy Scott, Allison Morgan, Mariet Benade, Vinolia Ntjikelane, Linda Sande, Lufuno Malala, Musa Manganye, Sydney Rosen, Radhika Sundararajan
PLOS Global Public Health vol: 5 issue: 12 first page: e0004977 year: 2025
doi: 10.1371/journal.pgph.0004977
8. The Changing Global Epidemic of HIV and Ocular Disease
Remco P. H. Peters, Philippe G. Kestelyn, Manfred Zierhut, John H. Kempen
Ocular Immunology and Inflammation vol: 28 issue: 7 first page: 1007 year: 2020
doi: 10.1080/09273948.2020.1751214
9. Recent HIV infection among pregnant women in the 2017 antenatal sentinel cross–sectional survey, South Africa: Assay–based incidence measurement
Selamawit Woldesenbet, Tendesayi Kufa-Chakezha, Carl Lombard, Samuel Manda, Mireille Cheyip, Kassahun Ayalew, Brian Chirombo, Peter Barron, Karidia Diallo, Bharat Parekh, Adrian Puren, Marcel Yotebieng
PLOS ONE vol: 16 issue: 4 first page: e0249953 year: 2021
doi: 10.1371/journal.pone.0249953
10. Same-day antiretroviral therapy initiation for HIV-infected adults in South Africa: Analysis of routine data
Rivka R. Lilian, Kate Rees, James A. McIntyre, Helen E. Struthers, Remco P. H. Peters, Marcel Yotebieng
PLOS ONE vol: 15 issue: 1 first page: e0227572 year: 2020
doi: 10.1371/journal.pone.0227572
11. CD4 testing after initiation of antiretroviral therapy: Analysis of routine data from the South African HIV programme
Rivka R. Lilian, Natasha Davies, Louise Gilbert, James A. McIntyre, Helen E. Struthers, Kate Rees
Southern African Journal of HIV Medicine vol: 21 issue: 1 year: 2020
doi: 10.4102/sajhivmed.v21i1.1165
12. Diagnostic accuracy of the WHO clinical staging system for detection of immunologically defined advanced HIV disease: A systematic review and meta‐analysis
Hussein H. Twabi, Akitoshi Ueno, Josephine Ives, Ross Murtagh, Madalo Mukoka, Seyed Alireza Mortazavi, David S. Lawrence, Augustine T. Choko, Robina Semphere, Kelvin Balakasi, Ajay Rangaraj, Nathan Ford, Joseph N. Jarvis, Peter MacPherson
HIV Medicine vol: 27 issue: 1 first page: 120 year: 2026
doi: 10.1111/hiv.70122
13. Pulse wave velocity demonstrates increased aortic stiffness in newly diagnosed, antiretroviral naïve HIV infected adults: A case-control study
Pieter-Paul S. Robbertse, Anton F. Doubell, Steve Innes, Carl J. Lombard, Philip G. Herbst
Medicine vol: 101 issue: 34 first page: e29721 year: 2022
doi: 10.1097/MD.0000000000029721
14. The fall—And rise—In hospital-based care for people with HIV in South Africa: 2004–2017
Evelyn Lauren, Khumbo Shumba, Matthew P. Fox, William MacLeod, Wendy Stevens, Koleka Mlisana, Jacob Bor, Dorina Onoya, Claudia P. Cortes
PLOS Global Public Health vol: 4 issue: 9 first page: e0002127 year: 2024
doi: 10.1371/journal.pgph.0002127
15. Incidence of HIV-positive admission and inpatient mortality in Malawi (2012–2019)
Rachael M. Burke, Marc Y.R. Henrion, Jane Mallewa, Leo Masamba, Thokozani Kalua, McEwen Khundi, Ankur Gupta-Wright, Jamie Rylance, Stephen B. Gordon, Clemens Masesa, Elizabeth L. Corbett, Henry C. Mwandumba, Peter Macpherson
AIDS vol: 35 issue: 13 first page: 2191 year: 2021
doi: 10.1097/QAD.0000000000003006
16. Understanding the Reasons for Deferring ART Among Patients Diagnosed Under the Same-Day-ART Policy in Johannesburg, South Africa
Dorina Onoya, Tembeka Sineke, Idah Mokhele, Jacob Bor, Matthew P. Fox, Jacqui Miot
AIDS and Behavior vol: 25 issue: 9 first page: 2779 year: 2021
doi: 10.1007/s10461-021-03171-6
17. HIV epidemic control in South Africa: An analysis of shifting responsibilities between 2011 and 2019
Hanlie Myburgh
Global Public Health vol: 20 issue: 1 year: 2025
doi: 10.1080/17441692.2025.2576752
18. Antiretroviral Therapy and HIV-Associated Cardiovascular Disease: A Prospective Cardiac Biomarker and CMR Tissue Characterization Study
Pieter-Paul S. Robbertse, Anton F. Doubell, Tonya M. Esterhuizen, Philip G. Herbst
ESC Heart Failure vol: 11 issue: 2 first page: 748 year: 2024
doi: 10.1002/ehf2.14603
19. Prevalence, Predictors, and Outcomes of HIV Care in HIV‐Positive Clients Entering HIV Care With Advanced HIV Disease in Sub‐Saharan Africa 2010–2022: Systematic Review and Meta‐Analysis
Samson Haumba, Shreya Arora, Victor Williams, Thokozani Maseko, Arnold Mafukidze, Sylvia Ojoo
Health Science Reports vol: 7 issue: 12 year: 2024
doi: 10.1002/hsr2.70285
20. Evaluating compliance with quality indicators of HIV and AIDS clinical care and analyzing those associated with mortality in the Democratic Republic of Congo
Tambwe Willy Muzumbukilwa, Bihehe Masemo Dieudonne, Riziki Ghislain Manimani, Aganze Gloire Mushebenge, Rajesh Vikram Vagiri, Manimbulu Nlooto
BMC Infectious Diseases vol: 24 issue: 1 year: 2024
doi: 10.1186/s12879-024-10253-y
21. Point-of-care CD4 testing: Differentiated care for the most vulnerable
Elizabeth Spooner, Tarylee Reddy, Nobuhle Mchunu, Shabashini Reddy, Brodie Daniels, Noluthando Ngomane, Nozipho Luthuli, Photini Kiepiela, Anna Coutsoudis
Journal of Global Health vol: 12 year: 2022
doi: 10.7189/jogh.12.04004
22. Preferences for services in a patient’s first six months on antiretroviral therapy for HIV in South Africa and Zambia (PREFER): research protocol for a prospective observational cohort study
Mhairi Maskew, Vinolia Ntjikelane, Allison Juntunen, Nancy Scott, Mariet Benade, Linda Sande, Pamfred Hasweeka, Prudence Haimbe, Priscilla Lumano-Mulenga, Hilda Shakewelele, Mpande Mukumbwa-Mwenechanya, Sydney Rosen
Gates Open Research vol: 7 first page: 119 year: 2023
doi: 10.12688/gatesopenres.14682.1
23. Supporting re-engagement with HIV services after treatment interruption in South Africa: a mixed method program evaluation of MSF’s Welcome Service
Kirsten D. Arendse, Caroline Walker, Colin Pfaff, Keitumetse Lebelo, Tali Cassidy, Petros Isaakidis, Erin von der Heyden, Fareed Abdullah, Tom Ellman, Ingrid T. Katz, Jonathan Euvrard, Claire M. Keene
Scientific Reports vol: 14 issue: 1 year: 2024
doi: 10.1038/s41598-024-57774-9
24. HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals
Alexandra Duhant, Byabene Kusinza, Claire Tantet, Basimane Bisimwa, Mathilde Gare, Bihehe Masemo, Chakib Alloui, Mukanire Ntakwinjan, Frédéric Mechai, Minh Patrick Le, Athenaïs Gerber, Balthazar Muhigirwa, Gilles Peytavin, Emmanuel Gordien, Ségolène Brichler, Mukengere Mukwege, Frédéric Le Gal
Journal of Antimicrobial Chemotherapy vol: 78 issue: 7 first page: 1732 year: 2023
doi: 10.1093/jac/dkad163
25. Characteristics and six-month viral load suppression of clients presenting with advanced HIV disease in South Africa
Elizabeth Kachingwe, Nyasha Mutanda, Vinolia Ntjikelane, Mariet Benade, Musa Manganye, Lufuno Malala, Sydney Rosen, Mhairi Maskew, Sizulu Moyo
PLOS Global Public Health vol: 5 issue: 9 first page: e0004927 year: 2025
doi: 10.1371/journal.pgph.0004927
26. Preferences for services in a patient’s first six months on antiretroviral therapy for HIV in South Africa and Zambia (PREFER): research protocol for a prospective observational cohort study
Mhairi Maskew, Vinolia Ntjikelane, Allison Juntunen, Nancy Scott, Mariet Benade, Linda Sande, Pamfred Hasweeka, Prudence Haimbe, Priscilla Lumano-Mulenga, Hilda Shakewelele, Mpande Mukumbwa-Mwenechanya, Sydney Rosen
Gates Open Research vol: 7 first page: 119 year: 2024
doi: 10.12688/gatesopenres.14682.2